Increasing mortality due to chronic and cardiovascular diseases especially in the elderly population is a major factor boosting the growth of the market.

Increasing use of inoculation turntable for even streaking in microbiology and pharmaceutical industry is expected to boost growth of the inoculating turntables market.

The global disposable blood bags market size was valued at US$ 230.1 million in 2017, and is expected to witness a CAGR of 12.1% over the forecast period (2018 – 2026).

Technetium-99m – Widely used Radioisotope in Diagnostic Procedures fueling growth of the radiopharmaceuticals market

The global geriatric care services market was valued at US$ 599.6 billion in 2015 and is expected to expand at a CAGR of 4.2% during the forecast period (2016 – 2024).

The global dental implants market revenue was valued at US$ 3,619.0 million in 2016 and is expected to expand at a CAGR of 6.3% during 2016 – 2024.

The global triptorelin market size was valued at US$ 426.4 Mn in 2017, and is expected to witness a CAGR of 5.2% over the forecast period (2018 – 2026).

Increasing launches and approval of novel drugs in key regions are expected to fuel the global hyperphosphatemia drugs market growth in near future.

The global petri dish market size was valued at US$ 155.2 million in 2017, and is expected to witness a CAGR of 3.6% over the forecast period (2018 – 2026).

The global combination treatment in aesthetics market size was valued at US$ 2334 million in 2017, and is expected to witness a CAGR of 9.1% over the forecast period (2018 – 2026).

High incidence rate of metabolic disorders is expected to propel growth of peptide therapeutics in metabolic disorders market in the near future.

Increasing incidence and prevalence of colon and rectal cancer, worldwide and increasing research and development studies for colorectal cancer treatment is expected to drive growth of colon and rectal cancer market

North America dominated the periodontal disease therapeutics market due to high awareness of periodontal disease.

High prevalence of respiratory infections due to RSV is a major factor driving growth of the respiratory syncytial virus diagnostics market. 

High prevalence of CLL coupled with its high mortality rate, demonstrates the unmet market need for better therapeutics.

Rising geriatric population worldwide would be another impetus for growth of the H1N1 vaccine market.

Increase in the number of cardio vascular disease to boost the angioplasty balloon market

Effective treatment through minimally invasive catheter-based endovascular procedure to drive renal denervation devices market growth

Increase in investment in research and development for new medicines is accounting for the growth of novel drug delivery systems market in North America

Technological advancements in cardiac implant to drive the implantable medical devices market

Non-woven disposable products offers opportunities for favorable growth of the medical non-woven disposables market.

Advanced approaches for the treatment of AID is expected favor the growth of autoimmune disease treatment market

Technological advancement in sensing devices and introduction of key players into the market is expected to boost the growth of Wearable Sensors Market

Rising prevalence of muscular dystrophies with unspecific current medications is expected to fuel the muscular dystrophies treatment market

High intake of alcohol and drugs is major cause of snoring, which is expected to augment the anti-snoring treatment market growth

Targeted cancer therapies market is growing due to the increasing incidences of cancers such as breast cancer, lung cancer, colorectal and among others.

Laboratory equipment includes important aspects in healthcare, medical and pharmaceutical research study.

Increasing R&D activities to launch new products is expected to support in growth of the cardiovascular drugs market

Development of first-of-its-kind therapeutic approach to treat carcinoid syndrome diarrhea creates highly lucrative growth opportunities for market players.

Personalized medicine and advanced technologies such as assay performance and drug monitoring to fuel the growth of therapeutic drug monitoring market

Rising incidence of leukemia and lymphoma and continuous research on hematopoietic stem cells are expected to drive market growth

Introduction of novel immune-oncology therapies with lesser side effects is driving growth of the global immune-oncology drugs market

Development of technologically advanced cardiac monitoring devices is expected to boost the cardiac monitoring devices market growth

The global pulmonary drugs market was valued at US$ 28.1 billion in 2016 and is expected to witness a robust CAGR of 8.1% over the forecast period (2017 - 2025).

Increasing prevalence of diabetes and robust development in technology is expected to drive growth of the market over the forecast period

The global multiple sclerosis therapeutics market was valued at US$ 19.6 billion in 2016 and is expected to witness a robust CAGR of 2.5% over the forecast period (2017 - 2025).

Rapid approval of biosimilars for oncology is expected to be a major driving factor for growth of the oncology biosimilars market over the forecast period

Adoption of these systems by various hospitals is expected to propel the growth of the Image guided therapy systems market

The global radiotherapy market was valued at US$ 5,253.7 million in 2016 and is expected to witness a robust CAGR of 6.8% over the forecast period (2017 - 2025).

Vaccine manufacturers are focusing on partnering with organizations such WHO, UNICEF, and GAVI Alliance to improve their vaccination programs, in order to reach the maximum population to offer vaccines.

The global POC platform & technology market was valued at US$ 21,370.3 Million in 2016 and is expected to exhibit a robust CAGR of 8.9% over the forecast period (2017 – 2025).

North America is expected to be the dominant market in the global SLE treatment market, over the forecast period. 

Patent expiration of branded products and drug resistance to antifungal medications are the factors restraining growth of the market.

Increasing prevalence of respiratory related diseases around the globe is expected to propel the global disposable oxygen masks market growth over the forecast period. 

Increasing prevalence of various chronic diseases such as hepatitis, sepsis, tuberculosis, and HIV is expected to propel growth of the procalcitonin antibody market.

Increasing efforts by major players to introduce low-cost advanced products is expected strengthen the antimicrobial wound dressing market growth.

Increasing prevalence of cancer and failure of conventional methods to treat the disease effectively have led to increasing demand for new immunotherapy-based therapy such as peptide vaccine.

North America is expected to be the dominant region in the global antisense oligonucleotides market over the forecast period

The global Helicobacter pylori diagnostics market size was valued at US$ 437.3 million in 2017 and is expected to witness a CAGR of 7.1% over the forecast period (2018 – 2026).

The global retroperitoneal liposarcoma treatment market is expected to exhibit a moderate growth rate, owing to low incidence of this disease across the globe.